StonvexLoading…
StonvexStonvexStonvexCore line items from FTNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.80B | $5.96B | $5.30B | $4.42B |
Operating Income | $2.08B | $1.80B | $1.24B | $969.60M |
Net Income | $1.85B | $1.75B | $1.15B | $857.30M |
EPS (Diluted) | $2.42 | $2.26 | $1.46 | $1.06 |
Total Assets | $10.39B | $9.76B | $7.26B | $6.23B |
Total Liabilities | $9.15B | $8.27B | $7.72B | $6.51B |
Cash & Equivalents | $2.50B | $2.88B | $1.40B | $1.68B |
Free Cash Flow OCF − CapEx | $2.23B | $1.88B | $1.73B | $1.45B |
Shares Outstanding | 743.00M | 767.00M | 761.00M | 781.50M |